Pyridinolone palladium complex (PdPT), a broad-spectrum deubiquitinase inhibitor, can promote the death of non-small cell lung cancer cells by inducing the degradation of GPX4 protein [141]. Here, GPX4 is linked to non-small cell lung carcinoma.